Consumer Protection grants
47 federal consumer protection grant opportunities are open or forecast now, from 2 agencies.
- Minor Use Minor Species Development of Drugs (R01)
Open - Animal Food Regulatory Program Standards Implementation Development and Maintenance, with Mutual Reliance Initiatives Clinical Trials Not Allowed
Open - NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens
Open - Laboratory Flexible Funding Model (LFFM)
Open - Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)
Open - Animal and Veterinary Innovation Centers (U18)
Open - Reissue of RFA-FD-23-001- Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required)
Open - Vet-LIRN Capacity-Building Project and Equipment Grants (U18)
Open - FY26 US DOT Drone Infrastructure Inspection Grants (DIIG) Program
Forecast - Manufactured Foods Flexible Funding Model (MF-FFM)
Forecast - Utilizing Real-World Data and Algorithmic Analyses to Assess Post-Market Clinical Outcomes in Patients Switching Amongst Therapeutically Equivalent Complex Generic Drug Products and Reference Listed Drugs (U01) Clinical Trial Not Allowed
Forecast - Evaluating the Cutaneous Pharmacokinetics of Topical Drug Products Using Pharmacokinetic Tomography (U01 Clinical Trial Required)
Forecast - Improving Predictability of Food-Drug and Drug-Drug Interaction Risks by Utilizing In Vitro Simulated Gastrointestinal Dissolution Model for High-Risk Oral Drug Products (U01) Clinical Trial Optional
Forecast - Identification of Drug-related and Formulation-Related Factors that Result in Alcohol Dose Dumping of Modified Release Oral Drug Products (U01) Clinical Trial Not Allowed
Forecast - Synthesis and Biological Activity Assessment of Different Diastereomers in siRNA Drug LEQVIO (Inclisiran) (U01) Clinical Trial Not Allowed
Forecast - Identification and Evaluation of Possible Approaches to Addressing Nitrosamine Impurities in Drugs (U01)
Forecast - Flexible Funding Model-Infrastructure Development and Maintenance for State Manufactured Food Regulatory Programs (U2F) Clinical Trials Not Allowed
Forecast - Cooperative Agreement to Support a Human Abuse Potential Study of Botanical Kratom (U01 Clinical Trial Required)
Forecast - Critical Path Public Private Partnerships Clinical Trials Optional
Forecast - Minor Use Minor Species Development of Drugs (R01)
Forecast - Collaborations to Enhance Drug Development and Regulatory Science
Forecast - Development and Maintenance of Human and Animal Food Rapid Response Teams (U2F) Clinical Trials Not Allowed
Forecast - FDA OMHHE Health Equity Innovation Award: Enhance Equity Funding Opportunity (U01) Clinical Trials Not Allowed
Forecast - OMHHE Educational Funding Opportunity: Expanding education on skin lightening products (U01) Clinical Trials Not Allowed
Forecast - Animal Food Regulatory Program Alliance
Forecast - Animal Food Regulatory Program Standards Implementation Development and Maintenance, with Mutual Reliance Initiatives
Forecast - Center for Research on Complex Generics (U18) Clinical Trials Optional
Forecast - Integrated Food Safety System Regulatory and Laboratory Training System National Coordination Center
Forecast - Studies Addressing Rare Neurodegenerative Diseases including ALS
Forecast - Retail Food Safety Regulatory Association Collaboration CAP
Forecast - Cooperative Agreement to Support Activities Related to Analgesics, Anesthetics, and Addiction (U01) Clinical Trials Allowed
Forecast - Cooperative Agreement to Support Effective Dissemination of Clinical Practice Guidelines
Forecast - Health Equity Innovation Award: Enhance Equity Funding Opportunity (U01) Clinical Trials Not Allowed
Forecast - REACHing Communities (REACH) Consortium (U01) Clinical Trials Optional
Forecast - Educational Funding Opportunity: Expanding education on skin lightening products (U01) Clinical Trials Not Allowed
Forecast - Clinical Trials Addressing Unmet Needs of Rare Neurodegenerative Diseases (R01) Clinical Trials Required
Forecast - NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens
Forecast - Applied regulatory science research to evaluate and treat cardiotoxicity of oncology therapeutics
Forecast - Food Safety Capacity and Infrastructure Building (U2F)
Forecast - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)
Forecast - Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required)
Forecast - Conformance with the Egg Regulatory Program Standards
Forecast - FDA's Integrated Food Safety System Training Delivery and Development
Forecast - Federal and State Integration Activities to Advance Cooperation and Regulatory Standards Among Animal Food Safety Regulatory Programs
Forecast - Reducing Fraud and Lowering Barriers to the Production of Drugs in Shortage by Outsourcing Facilities
Forecast - Retail Food Safety Regulatory Association Collaboration
Forecast - Novel approaches to support therapeutic development in ultra-rare cancers
Forecast